Global Octreotide Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Octreotide market size will reach 3.20 Million USD in 2025 and is projected to reach 2.73 Million USD by 2032, with a CAGR of -2.26% (2025-2032). Notably, the China Octreotide market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Octreotide is a synthetic peptide hormone that is derived from natural somatostatin. It is primarily used in medical applications as a medication to treat various conditions related to hormonal and neoplastic disorders. Octreotide works by binding to specific receptors on cells, inhibiting the release of various hormones such as growth hormone, insulin, glucagon, and certain gastrointestinal hormones. This hormone regulation can be beneficial in managing conditions like acromegaly, carcinoid syndrome, VIPomas, and severe diarrhea caused by certain tumors or medical procedures. Octreotide is available in different formulations, including injectable, long-acting depot injections, and subcutaneous implants, allowing for flexible dosing and administration options. While it is generally well-tolerated, common side effects may include gastrointestinal disturbances, such as nausea, abdominal pain, and diarrhea. Octreotide requires a prescription and should be used under the supervision and guidance of a healthcare professional.
The major global manufacturers of Octreotide include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals, Yibin Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Octreotide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Octreotide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Octreotide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Octreotide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Octreotide Include:
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide Product Segment Include:
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide Product Application Include:
Treating Severe Diarrhea
Treating Acromegaly
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Octreotide Industry PESTEL Analysis
Chapter 3: Global Octreotide Industry Porter's Five Forces Analysis
Chapter 4: Global Octreotide Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Octreotide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Octreotide Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Octreotide Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Octreotide market size will reach 3.20 Million USD in 2025 and is projected to reach 2.73 Million USD by 2032, with a CAGR of -2.26% (2025-2032). Notably, the China Octreotide market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Octreotide is a synthetic peptide hormone that is derived from natural somatostatin. It is primarily used in medical applications as a medication to treat various conditions related to hormonal and neoplastic disorders. Octreotide works by binding to specific receptors on cells, inhibiting the release of various hormones such as growth hormone, insulin, glucagon, and certain gastrointestinal hormones. This hormone regulation can be beneficial in managing conditions like acromegaly, carcinoid syndrome, VIPomas, and severe diarrhea caused by certain tumors or medical procedures. Octreotide is available in different formulations, including injectable, long-acting depot injections, and subcutaneous implants, allowing for flexible dosing and administration options. While it is generally well-tolerated, common side effects may include gastrointestinal disturbances, such as nausea, abdominal pain, and diarrhea. Octreotide requires a prescription and should be used under the supervision and guidance of a healthcare professional.
The major global manufacturers of Octreotide include Novartis, Sun Pharmaceutical, Chengdu Tiantaishan pharmaceutical, Sinopharm A-Think Pharmaceuticals, Sihuan Pharmaceutical Holdings Group, Shanghai Soho-Yiming Pharmaceuticals, Yibin Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Octreotide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Octreotide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Octreotide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Octreotide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Octreotide Include:
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Octreotide Product Segment Include:
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Octreotide Product Application Include:
Treating Severe Diarrhea
Treating Acromegaly
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Octreotide Industry PESTEL Analysis
Chapter 3: Global Octreotide Industry Porter's Five Forces Analysis
Chapter 4: Global Octreotide Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Octreotide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Octreotide Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Octreotide Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Octreotide Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Octreotide Product by Type
- 1.2.1 Octreotide Injection
- 1.2.2 Octreotide Powder
- 1.2.3 Octreotide Microspheres
- 1.3 Octreotide Product by Application
- 1.3.1 Treating Severe Diarrhea
- 1.3.2 Treating Acromegaly
- 1.3.3 Others
- 1.4 Global Octreotide Market Revenue and Sales Analysis
- 1.4.1 Global Octreotide Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Octreotide Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Octreotide Market Sales Price Trend Analysis (2020-2032)
- 1.5 Octreotide Market Development Status and Trends
- 1.5.1 Octreotide Industry Development Status Analysis
- 1.5.2 Octreotide Industry Development Trends Analysis
- 2 Octreotide Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Octreotide Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Octreotide Market Analysis by Country
- 4.1 Global Octreotide Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Octreotide Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Octreotide Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Octreotide Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Octreotide Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Octreotide Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Octreotide Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Octreotide Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Octreotide Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Octreotide Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Octreotide Average Sales Price by Manufacturers (2021-2025)
- 5.2 Octreotide Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Octreotide Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Octreotide Market Analysis by Type
- 6.1 Global Octreotide Market Revenue Analysis by Type
- 6.1.1 Global Octreotide Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Octreotide Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Octreotide Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Octreotide Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Novartis
- 7.1.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Novartis Octreotide Product Portfolio
- 7.1.3 Novartis Octreotide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Sun Pharmaceutical
- 7.2.1 Sun Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Sun Pharmaceutical Octreotide Product Portfolio
- 7.2.3 Sun Pharmaceutical Octreotide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Chengdu Tiantaishan pharmaceutical
- 7.3.1 Chengdu Tiantaishan pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Chengdu Tiantaishan pharmaceutical Octreotide Product Portfolio
- 7.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Sinopharm A-Think Pharmaceuticals
- 7.4.1 Sinopharm A-Think Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Sinopharm A-Think Pharmaceuticals Octreotide Product Portfolio
- 7.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Sihuan Pharmaceutical Holdings Group
- 7.5.1 Sihuan Pharmaceutical Holdings Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Sihuan Pharmaceutical Holdings Group Octreotide Product Portfolio
- 7.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Shanghai Soho-Yiming Pharmaceuticals
- 7.6.1 Shanghai Soho-Yiming Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Shanghai Soho-Yiming Pharmaceuticals Octreotide Product Portfolio
- 7.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Yibin Pharmaceutical
- 7.7.1 Yibin Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Yibin Pharmaceutical Octreotide Product Portfolio
- 7.7.3 Yibin Pharmaceutical Octreotide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Octreotide Industry Chain Analysis
- 8.2 Octreotide Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Octreotide Product Downstream Application Analysis
- 8.3.1 Global Octreotide Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Octreotide Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Octreotide Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Octreotide Typical Downstream Customers
- 8.5 Octreotide Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
